Lit­tle Aziyo is grow­ing a new re­gen­er­a­tive med com­pa­ny, led by some fa­mil­iar faces in the biz

A few days ago, the small re­gen­er­a­tive med­i­cine com­pa­ny Aziyo Bi­o­log­ics re­port­ed to the SEC that it had raised $12 mil­lion, just as it was in the process of buy­ing out a small, Geor­gia-based com­pa­ny called Cor­Ma­trix Car­dio­vas­cu­lar.

The deal put to­geth­er some very fa­mil­iar faces in the re­gen­er­a­tive med­i­cine world with close ties to Osiris Ther­a­peu­tics, one of the pi­o­neers in re­gen­er­a­tive med­i­cine which has been strug­gling to re­state sev­er­al years of earn­ings — a strug­gle that spurred Nas­daq re­cent­ly to kick the stock over to the Pink Sheets.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.